This project is a double-blind, randomized, placebo-controlled, multicenter trial in the
Netherlands. The aim of this study is to investigate the therapeutic efficacy of optimized
6-mercaptopurine (6-MP) in ulcerative colitis patients. Therapeutic drug monitoring (TDM)
will be performed in order to optimize treatment outcomes and objective endoscopic endpoints
will be used.
Phase:
Phase 3
Details
Lead Sponsor:
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
Collaborator:
ZonMw: The Netherlands Organisation for Health Research and Development